Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma

OBJECTIVE: We investigated the prognostic clinicopathologic factors associated with overall survival (os) and progression-free survival (pfs) in the once-daily continuous administration of first-line sunitinib in a consecutive cohort of Turkish patients with metastatic renal cell carcinoma (rcc). ME...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yildiz, I., Sen, F., Kilic, L., Ekenel, M., Ordu, C., Kilicaslan, I., Darendeliler, E., Tunc, H.M., Varol, U., Bavbek, S., Basaran, M.
Format: Artigo
Jezik:Inglês
Izdano: Multimed Inc. 2013
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3851351/
https://ncbi.nlm.nih.gov/pubmed/24311955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.20.1596
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki